Kommuniqué I
Liebe Freunde, Aktionäre, Wir sind in ein neues Jahr eingetreten, eines voller...
Read More
CLINUVEL Communiqué I
Dear friends, shareholders, We have entered a new year, one brimmed with...
Read More
CLINUVEL Newsletter VI
Dear shareholders, friends, CLINUVEL’S OUTLOOK The past weeks have seen a flurry...
Read More
SCIENTIFIC COMMUNIQUÉ VIII
DNA Repair Mechanisms December 2020 Introduction DNA is the repository of genetic...
Read More
SCIENTIFIC COMMUNIQUÉ VII
The Cerebral Vasculature System in Disease: Atherosclerosis Introduction The human brain is...
Read More
Chair's Letter To Shareholders
19 November 2020 Dear fellow shareholder, I look back at a year...
Read More
SCIENTIFIC COMMUNIQUÉ VI
Ultraviolet Radiation Damage and Oxidative Stress in Skin Cancer. October 2020 Introduction...
Read More
Kommuniqué V, 20-23 September 2020
Liebe Aktionäre, Freunde, Während die Welt darum kämpft, die Verbreitung von...
Read More
CLINUVEL Newsletter V
Dear shareholders, friends, As the world battles on to control the...
Read More
CLINUVEL Newsletter
Dear shareholders, friends, As a new world presents itself indicating that the...
Read More
CLINUVEL Vitiligo Communiqué II
12 February 2019 In the second Communiqué we look closer at...
Read More
CLINUVEL Vitiligo Communiqué
19 December 2018 As a depigmentation disorder hypomelanosis vitiligo is the most...
Read More